EFFECT OF COMBINED THERAPY WITH LYMPHOKINE-ACTIVATED KILLER CELLS, INTERLEUKIN-2 AND SPECIFIC MONOCLONAL-ANTIBODY ON ESTABLISHED B-16 MELANOMA LUNG METASTASES

被引：0
|
作者：
EISENTHAL, A
CAMERON, RB
UPPENKAMP, I
ROSENBERG, SA
机构：
来源：
CANCER RESEARCH | 1988年 / 48卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7140 / 7145
页数：6
相关论文
共 50 条
  • [41] SYNERGY OF HUMAN RECOMBINANT INTERLEUKIN-1 WITH INTERLEUKIN-2 IN THE GENERATION OF LYMPHOKINE-ACTIVATED KILLER CELLS
    CRUMP, WL
    OWENSCHAUB, LB
    GRIMM, EA
    CANCER RESEARCH, 1989, 49 (01) : 149 - 153
  • [42] PULMONARY TOXICITY OF RECOMBINANT INTERLEUKIN-2 PLUS LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY
    VILLANI, F
    GALIMBERTI, M
    RIZZI, M
    MANZI, R
    EUROPEAN RESPIRATORY JOURNAL, 1993, 6 (06) : 828 - 833
  • [43] ACALCULUS LYMPHOEOSINOPHILIC CHOLECYSTITIS ASSOCIATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY
    CHUNGPARK, M
    KIM, B
    MARMOLYA, G
    KARLINS, N
    WOJCIK, E
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1990, 114 (10) : 1073 - 1075
  • [44] SEVERE INTRAHEPATIC CHOLESTASIS IN PATIENTS TREATED WITH RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    HOFFMAN, M
    MITTELMAN, A
    DWORKIN, B
    ROSENTHAL, W
    BENECK, D
    GAFNEY, E
    ARLIN, Z
    LEVITT, D
    PODACK, E
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (02) : 175 - 178
  • [45] EFFECT OF INTERLEUKIN-2 AND COLONY-STIMULATING FACTORS ON THE ANTIBODY-DEPENDENT CELLULAR CYTOTOXITY OF LYMPHOKINE-ACTIVATED KILLER CELLS AND GRANULOCYTES
    HANDGRETINGER, R
    BRUCHELT, G
    KIMMIG, A
    OTTENLINGER, C
    REISFELD, RA
    TREUNER, J
    NIETHAMMER, D
    BLUT, 1988, 57 (04): : 184 - 184
  • [46] CANCER-IMMUNOTHERAPY - CURRENT STATUS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    VANHAELSTPISANI, CM
    PISANI, RJ
    KOVACH, JS
    MAYO CLINIC PROCEEDINGS, 1989, 64 (04) : 451 - 465
  • [47] A NEW REGIMEN OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - EFFICACY WITHOUT SIGNIFICANT TOXICITY
    EBERLEIN, TJ
    SCHOOF, DD
    JUNG, SE
    DAVIDSON, D
    GRAMOLINI, B
    MCGRATH, K
    MASSARO, A
    WILSON, RE
    ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (12) : 2571 - 2576
  • [48] EFFECTS OF ANTI-B16 MELANOMA MONOCLONAL-ANTIBODIES ON LYMPHOKINE ACTIVATED KILLER-CELLS DIRECTED AGAINST B-16 TARGETS
    BARTH, RF
    TZENG, JJ
    JOHNSON, CW
    ADAMS, DM
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (04) : 373 - 374
  • [49] INFLUENCE OF DIFFERENT CYTOKINES ON THE GENERATION OF INTERLEUKIN-2 INDUCED LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    BERGMANN, L
    WEIDMANN, E
    REUSCH, C
    MITROU, PS
    BLUT, 1988, 57 (04): : 248 - 248
  • [50] ALLOGENEIC LYMPHOKINE ACTIVATED KILLER (LAK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2) REDUCE ESTABLISHED PULMONARY METASTASES
    SHILONI, E
    MULE, JJ
    SCHWARZ, S
    ROSENBERG, SA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 362 - 362
12345